Lawsuit says ChatGPT persuaded person to stop taking epilepsy meds, leading to her death

Share This Post

A laptop keyboard and ChatGPT on App Store displayed on a phone screen

The parents of a 31-year-old Seattle woman are suing OpenAI, alleging the company’s AI chatbot led to her death, according to a new report from The New York Times.

Per the Times‘ report, the parents of Bowen Wan allege ChatGPT helped their daughter taper off the medication that controlled her severe epilepsy, and helped her hide the plan from her doctors in the weeks before she died. In February, Wan was found dead in her apartment; her official cause of death was sudden, unexpected death in epilepsy, the NYT reported. Her parents, Qun Wan and Meiqin Xu, filed the lawsuit the same day.

According to the Times, Wan had come to lean heavily on ChatGPT. Wan worked as a software engineer for Amazon; however, her worsening epilepsy symptoms forced her to take disability leave. After learning she would be laid off from Amazon, she grew worried that her medication was slowing her speech. She feared it would hurt her in the job interviews she needed to pass to stay in the U.S. Wan averaged more than 1,500 messages a week in 2025 while calling her parents less often.

The Times reports that ChatGPT drafted schedules that would take her off lamotrigine — a medication that treats epilepsy and bipolar disorder — entirely within weeks. It also endorsed cutting her pills without telling her doctor, and cast physicians’ caution as mere risk aversion. When she described symptoms resembling seizures, the chatbot repeatedly reassured her. The Times’ analysis found she raised concerns about the taper at least 158 times. Her neurologist told the Times he would never have considered tapering a patient with her history.

The lawsuit claims ChatGPT practiced medicine without a license and portrayed her doctors as obstacles. It also alleges the chatbot may have been less likely to refuse her requests for medical advice because she was chatting in Chinese.

An OpenAI spokesperson told the Times that the case was heartbreaking and that it involved an earlier version of ChatGPT that is no longer available. Wan used GPT-4o, which OpenAI pulled from the consumer app on Feb. 13, 2026, the day after the medical examiner believes she died. The spokesperson told the Times that newer models are better at recognizing when a situation needs urgent attention.

GPT-4o has a long record of complaints about sycophancy. In April 2025, OpenAI rolled back an update to the model after CEO Sam Altman admitted it had become “too sycophant-y and annoying,” as Mashable reported. At the time, users warned that a chatbot that agrees with everything could validate delusions and deepen mental health crises.

The Wan case joins a growing list of wrongful death lawsuits against OpenAI. The family of 16-year-old Adam Raine sued in August 2025, alleging ChatGPT validated his suicidal thinking. In a court filing, OpenAI denied responsibility and pointed to his mental health history and his violations of its usage policies, Mashable reported. That November, seven more lawsuits alleged ChatGPT contributed to wrongful deaths and assisted suicides.

If you’re feeling suicidal or experiencing a mental health crisis, please talk to somebody. You can call or text the 988 Suicide & Crisis Lifeline at 988, or chat at 988lifeline.org.


Disclosure: Ziff Davis, Mashable’s parent company, filed a lawsuit against OpenAI in April 2025, alleging it infringed Ziff Davis copyrights in training and operating its AI systems. The New York Times has also sued OpenAI.

Subscribe The Newsletter

Get updates and learn from the best

More To Explore

Do You Want To Stay Connected?

drop a line and keep in touch